Skip to main content
Top
Published in: Clinical Rheumatology 1/2012

01-01-2012 | Original Article

Relationship between psoriatic arthritis and moderate–severe psoriasis: analysis of a series of 166 psoriatic arthritis patients selected from a hospital population

Authors: Noemi Busquets-Pérez, Jesus Rodriguez-Moreno, Carmen Gómez-Vaquero, Joan M. Nolla-Solé

Published in: Clinical Rheumatology | Issue 1/2012

Login to get access

Abstract

The aim of the study was to assess the prevalence of moderate to severe psoriasis (MS-P) in patients with psoriatic arthritis (PsA) and the relationship between MS-P and other variables related to arthritis. One hundred sixty-six consecutive patients with PsA periodically monitored at a university hospital’s PsA unit in northeastern Spain were included in the study. Patients with psoriasis were classified as having MS-P when systemic treatment for skin was required. Clinical criteria for treatment indication was BSA >10 and/or PASI >14 and/or psoriasis affecting a very sensitive area of the body. Demographic and clinical data related to arthritis were assessed, including PsA pattern, age of onset of psoriasis and arthritis, disease activity index, and treatment required over the course of the disease. Moderate–severe psoriasis were more prevalent in women (p = 0.027). One hundred nine patients (65.7%) had psoriatic nail disease, and MS-P was more frequent in these patients (40 (77%) vs. 69 (61%), p = 0.028). Patients with spondyloarthropathy were significantly associated with MS-P (7 (16%) vs. 3 (3%), p = 0.014). No statistical association was observed between severe psoriasis and the age of onset of psoriasis or arthritis, involvement of distal interphalangeal joints, laboratory findings (HLA B27, RF), functional class, or disease activity indices. We report a high prevalence of severe psoriasis among patients with psoriatic arthritis, higher in women and patients with psoriatic nail disease and axial spondyloarthropathy.
Literature
1.
go back to reference Gladman DD, Antoni C, Mease P, Clegg DO, Nash P (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64(Suppl 2):ii14–ii17PubMedCrossRef Gladman DD, Antoni C, Mease P, Clegg DO, Nash P (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64(Suppl 2):ii14–ii17PubMedCrossRef
2.
go back to reference Little H, Harvie JN, Lester RS (1975) Psoriatic arthritis in severe psoriasis. Can Med Assoc J 112:317–319PubMed Little H, Harvie JN, Lester RS (1975) Psoriatic arthritis in severe psoriasis. Can Med Assoc J 112:317–319PubMed
3.
go back to reference Reich K, Kruger K, Mossner R, Augustin M (2009) Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 160:1040–1047PubMedCrossRef Reich K, Kruger K, Mossner R, Augustin M (2009) Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol 160:1040–1047PubMedCrossRef
4.
go back to reference Taylor W, Gladman D, Helliwell P, Marchesoni A, Marchesoni P, Mielants H, CASPARStudy Group (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–2673PubMedCrossRef Taylor W, Gladman D, Helliwell P, Marchesoni A, Marchesoni P, Mielants H, CASPARStudy Group (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54(8):2665–2673PubMedCrossRef
5.
go back to reference Prevoo ML, ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48PubMedCrossRef Prevoo ML, ‘t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48PubMedCrossRef
6.
go back to reference Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed
7.
go back to reference Husted JA, Gladman DD, Long JA, Farewell VT (1995) A modified version of the Health Assessment Questionnaire (HAQ) for psoriatic arthritis. Clin Exp Rheumatol 13:439–443PubMed Husted JA, Gladman DD, Long JA, Farewell VT (1995) A modified version of the Health Assessment Questionnaire (HAQ) for psoriatic arthritis. Clin Exp Rheumatol 13:439–443PubMed
8.
go back to reference Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285PubMed Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285PubMed
9.
go back to reference Fredriksson T, Pettersson U (1978) Severe psoriasis—oral therapy with a new retinoid. Dermatologica 157:238–244PubMedCrossRef Fredriksson T, Pettersson U (1978) Severe psoriasis—oral therapy with a new retinoid. Dermatologica 157:238–244PubMedCrossRef
10.
go back to reference Puig L, Carrascosa JM, Dauden E, Sanchez-Carazo JL, Ferrandiz C, Sanchez-Regana M et al (2009) Spanish evidence-based guidelines on the treatment of moderate-to-severe psoriasis with biologic agents. Actas Dermosifiliogr 100:386–413PubMedCrossRef Puig L, Carrascosa JM, Dauden E, Sanchez-Carazo JL, Ferrandiz C, Sanchez-Regana M et al (2009) Spanish evidence-based guidelines on the treatment of moderate-to-severe psoriasis with biologic agents. Actas Dermosifiliogr 100:386–413PubMedCrossRef
11.
go back to reference Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T et al (2005) Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 53:573PubMedCrossRef Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T et al (2005) Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 53:573PubMedCrossRef
12.
go back to reference Scarpa R, Oriente P, Pucino A, Torella M, Vignone L, Riccio A et al (1984) Psoriatic arthritis in psoriatic patients. Br J Rheumatol 23:246–250PubMedCrossRef Scarpa R, Oriente P, Pucino A, Torella M, Vignone L, Riccio A et al (1984) Psoriatic arthritis in psoriatic patients. Br J Rheumatol 23:246–250PubMedCrossRef
13.
go back to reference Stern RS (1985) The epidemiology of joint complaints in patients with psoriasis. J Rheumatol 12:315–320PubMed Stern RS (1985) The epidemiology of joint complaints in patients with psoriasis. J Rheumatol 12:315–320PubMed
14.
go back to reference Leczinsky CG (1948) The incidence of arthropathy in a 10 year series of psoriasis cases. Acta Derm Venereol 28:483–487PubMed Leczinsky CG (1948) The incidence of arthropathy in a 10 year series of psoriasis cases. Acta Derm Venereol 28:483–487PubMed
15.
go back to reference Cohen MR, Reda DJ, Clegg DO (1999) Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies. J Rheumatol 26:1752–1756PubMed Cohen MR, Reda DJ, Clegg DO (1999) Baseline relationships between psoriasis and psoriatic arthritis: analysis of 221 patients with active psoriatic arthritis. Department of Veterans Affairs Cooperative Study Group on Seronegative Spondyloarthropathies. J Rheumatol 26:1752–1756PubMed
16.
go back to reference Wright V, Roberts MC, Hill AG (1979) Dermatological manifestations in psoriatic arthritis: a follow-up study. Acta Derm Venereol 59:235–240PubMed Wright V, Roberts MC, Hill AG (1979) Dermatological manifestations in psoriatic arthritis: a follow-up study. Acta Derm Venereol 59:235–240PubMed
17.
go back to reference Williamson L, Dalbeth N, Dockerty JL, Gee BC, Weatherall R, Wordsworth BP (2004) Extended report: nail disease in psoriatic arthritis–clinically important, potentially treatable and often overlooked. Rheumatology (Oxford) 43:790–794CrossRef Williamson L, Dalbeth N, Dockerty JL, Gee BC, Weatherall R, Wordsworth BP (2004) Extended report: nail disease in psoriatic arthritis–clinically important, potentially treatable and often overlooked. Rheumatology (Oxford) 43:790–794CrossRef
18.
go back to reference Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, McHugh NJ (1994) Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 33:834–839PubMedCrossRef Jones SM, Armas JB, Cohen MG, Lovell CR, Evison G, McHugh NJ (1994) Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease. Br J Rheumatol 33:834–839PubMedCrossRef
19.
go back to reference Scarpa R, Soscia E, Peluso R, Atteno M, Manguso F, Del Puente A et al (2006) Nail and distal interphalangeal joint in psoriatic arthritis. J Rheumatol 33:1315–1319PubMed Scarpa R, Soscia E, Peluso R, Atteno M, Manguso F, Del Puente A et al (2006) Nail and distal interphalangeal joint in psoriatic arthritis. J Rheumatol 33:1315–1319PubMed
20.
go back to reference Barraclough D, Russell AS, Percy JS (1977) Psoriatic spondylitis: a clinical, radiological, and scintiscan survey. J Rheumatol 4:282–287PubMed Barraclough D, Russell AS, Percy JS (1977) Psoriatic spondylitis: a clinical, radiological, and scintiscan survey. J Rheumatol 4:282–287PubMed
21.
go back to reference Reina SD, del Blanco J, Bonet M, Castano C, Clavaguera T, Mateo L et al (2007) Functional impairment in psoriatic arthritis. Multicentric study of 343 patients. Med Clin (Barc) 129:201–204CrossRef Reina SD, del Blanco J, Bonet M, Castano C, Clavaguera T, Mateo L et al (2007) Functional impairment in psoriatic arthritis. Multicentric study of 343 patients. Med Clin (Barc) 129:201–204CrossRef
Metadata
Title
Relationship between psoriatic arthritis and moderate–severe psoriasis: analysis of a series of 166 psoriatic arthritis patients selected from a hospital population
Authors
Noemi Busquets-Pérez
Jesus Rodriguez-Moreno
Carmen Gómez-Vaquero
Joan M. Nolla-Solé
Publication date
01-01-2012
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 1/2012
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-011-1787-1

Other articles of this Issue 1/2012

Clinical Rheumatology 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.